Active secretion of a thermostable transglutaminase variant in Escherichia coli.

Microb Cell Fact

National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, 1800 Lihu Road, Wuxi, 214122, Jiangsu, China.

Published: April 2022

Background: Streptomyces mobaraenesis transglutaminase (smTG) is widely used to generate protein crosslinking or attachment of small molecules. However, the low thermostability is a main obstacle for smTG application. In addition, it is still hard to achieve the secretory expression of active smTG in E. coli, which benefits the enzyme evolution. In this study, a combined strategy was conducted to improve the thermostability and secretory expression of active smTG in E. coli.

Results: First, the thermostable S. mobaraenesis transglutaminase variant S2P-S23V-Y24N-S199A-K294L (TGm1) was intracellularly expressed in pro-enzyme form in E. coli. Fusing the pro-region of Streptomyces hygroscopicus transglutaminase (proH) and TrxA achieved a 9.78 U/mL of intracellular smTG activity, 1.37-fold higher than the TGm1 fused with its native pro-region. After in vitro activation by dispase, the TGm1 with proH yielded FRAPD-TGm1, exhibiting 0.95 ℃ and 94.25% increases in melting temperature and half-life at 60 ℃ compared to FRAP-TGm1 derived from the expression using its native pro-region, respectively. Second, the TGm1 with proH was co-expressed with transglutaminase activating protease and chaperones (DnaK, DnaJ, and GrpE) in E. coli, achieving 9.51 U/mL of intracellular FRAPD-TGm1 without in vitro activation. Third, the pelB signal peptide was used to mediate the secretory expression of active TGm in E. coli, yielding 0.54 U/mL of the extracellular FRAPD-TGm1. A script was developed to shuffle the codon of pelB and calculate the corresponding mRNA folding energy. A 1.8-fold increase in the extracellular expression of FRAPD-TGm1 was achieved by the Top-9 pelB sequence derived from the coding sequences with the lowest mRNA folding energy. Last, deleting the gene of Braun's lipoprotein further increased the extracellular yield of FRAPD-TGm1 by 31.2%, reached 1.99 U/mL.

Conclusions: The stabilized FRAPD-smTG here could benefit the enzyme application in food and non-food sectors, while the E. coli system that enables secretory expression of active smTG will facilitate the directed evolution for further improved catalytic properties. The combined strategy (N-terminal modification, co-expression with chaperones, mRNA folding energy optimization of signal peptide, and lipoprotein deletion) may also improve the secretory expression of other functional proteins in E. coli.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052465PMC
http://dx.doi.org/10.1186/s12934-022-01801-9DOI Listing

Publication Analysis

Top Keywords

secretory expression
20
expression active
16
active smtg
12
mrna folding
12
folding energy
12
transglutaminase variant
8
mobaraenesis transglutaminase
8
combined strategy
8
native pro-region
8
vitro activation
8

Similar Publications

The current mechanism by which aging reduces salivary secretion is unknown. This study investigates the mechanism of aging-related submandibular (SMG) dysfunction and evaluates the therapeutic potential of dental pulp stem cell-derived exosomes (DPSC-exos). We found that the stimulated salivary flow rate was significantly reduced in naturally aging and D-galactose-induced aging mice (D-gal mice) compared to control mice.

View Article and Find Full Text PDF

Background: Patients with estrogen receptor (ER)-positive breast cancer (BC) can be treated with endocrine therapy targeting ER, however, metastatic recurrence occurs in 25% of the patients who have initially been treated. Secreted proteins from tumors play important roles in cancer metastasis but previous methods for isolating secretory proteins had limitations in identifying novel targets.

Methods: We applied an in situ secretory protein labeling technique using TurboID to analyze secretome from tamoxifen-resistant (TAMR) BC.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Guru Nanak Dev University, Amritsar, Punjab, India.

Background: Age-related neurological illness like Alzheimer's disease (AD) is steadily becoming more prevalent among the aged population in India and around the world. Cognitive deficits are caused by a progressive loss of normal brain functions. Increased production of amyloid (Aβ) and the development of neurofibrillary tangles (NFTs) are the two most significant pathogenic events that take place during AD progression.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Stanford University, School of Medicine, Stanford, CA, USA.

Background: The X-chromosome remains largely unexplored in Alzheimer's disease (AD). To address this gap, we performed the first large-scale X chromosome-wide association study (XWAS) of AD.

Method: The study overview is shown in Figure 1A.

View Article and Find Full Text PDF

Alzheimer's Imaging Consortium.

Alzheimers Dement

December 2024

Guru Nanak Dev University, Amritsar, Punjab, India.

Background: Age-related neurological illness like Alzheimer's disease (AD) is steadily becoming more prevalent among the aged population in India and around the world. Cognitive deficits are caused by a progressive loss of normal brain functions. Increased production of amyloid (Aß) and the development of neurofibrillary tangles (NFTs) are the two most significant pathogenic events that take place during AD progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!